C4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Inducement Grants have an exercise price per share that is equal to the closing price of C4T’s common stock on their respective Grant Dates. The Inducement Grants will vest over a four-year period, with 25% of the shares vesting on the first-year anniversary of the employee’s start date, and thereafter the remainder of the shares vesting in twelve equal quarterly installments, subject to each employee’s continued employment with C4T through each vesting date.
Senior Manager, Investor Relations
Director, Corporate Communications & Patient Advocacy
Source: C4 Therapeutics, Inc.